Dr. Lameirinhas Vieira Maracaja is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Manning Dr
Chapel Hill, NC 27514Phone+1 984-974-1000
Summary
- Dr. Danielle Lameirinhas Vieira Maracaja is a pathologist in Winston-Salem, NC and is affiliated with Wake Forest University School of Medicine and Atrium Health/ Wake Forest Baptist. She received her medical degree from Other and has been in practice 17 years. She specializes in blood banking & transfusion medicine, hematopathology, anatomic pathology, and clinical pathology.
Education & Training
- Yale-New Haven Medical CenterFellowship, Blood Banking/Transfusion Medicine, 2019 - 2020
- Yale-New Haven Medical CenterFellowship, Hematopathology, 2018 - 2019
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Pathology-Anatomic and Clinical, 2014 - 2018
- OtherClass of 2001
Certifications & Licensure
- NC State Medical License 2020 - 2025
- CT State Medical License 2018 - 2021
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Blood Banking/Transfusion Medicine
- American Board of Pathology Hematology
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 3 citationsThe use of low volume RBC units for transfusion.Emmanuel A Fadeyi, Christina S Warren, Danielle L V Maracaja, Gregory J Pomper
Transfusion. 2022-05-01 - 12 citationsHuman herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristics.Savanah D Gisriel, Ji Yuan, Ryan C Braunberger, Danielle L V Maracaja, Xueyan Chen
Modern Pathology. 2022-10-01 - 5 citationsClinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Patholo...Miguel D Cantu, Rashmi Kanagal-Shamanna, Sa A Wang, Tapan Kadia, Carlos E Bueso-Ramos
JCO Precision Oncology. 2023-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: